A Phase II Study of Gemcitabine in Combination with Tanespimycin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma

OBJECTIVE: To evaluate the efficacy and biological effects of the gemcitabine/tanespimycin combination in patients with advanced ovarian and peritoneal cancer. To assess the effect of tanespimycin on tumor cells, levels of the chaperone proteins HSP90 and HSP70 were examined in peripheral blood mono...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wahner Hendrickson, Andrea E., Oberg, Ann L., Glaser, Gretchen, Camoriano, John K., Peethambaram, Prema P., Colon-Otero, Gerardo, Erlichman, Charles, Ivy, Percy, Kaufmann, Scott H., Karnitz, Larry M., Haluska, Paul
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265019/
https://ncbi.nlm.nih.gov/pubmed/22047770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares